Catalent (CTLT) Stock Price, News & Analysis

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Catalent in the last twelve months. There are currently 1 sell rating, 9 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CTLT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CTLT, but not buy additional shares or sell existing shares.
View CTLT analyst ratings or view top-rated stocks.

13 equities research analysts have issued 12 month price objectives for Catalent's stock. Their CTLT share price targets range from $42.00 to $63.50. On average, they anticipate the company's stock price to reach $52.46 in the next year. This suggests that the stock has a possible downside of 6.5%.
View analysts price targets for CTLT or view top-rated stocks among Wall Street analysts.

Catalent's stock was trading at $44.93 at the beginning of 2024. Since then, CTLT shares have increased by 24.8% and is now trading at $56.08.
View the best growth stocks for 2024 here.

Catalent saw a increase in short interest in March. As of March 15th, there was short interest totaling 7,850,000 shares, an increase of 8.4% from the February 29th total of 7,240,000 shares. Based on an average trading volume of 2,700,000 shares, the short-interest ratio is currently 2.9 days.
View Catalent's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, June 10th 2024.
View our CTLT earnings forecast.

Catalent, Inc. (NYSE:CTLT) posted its quarterly earnings results on Friday, February, 9th. The company reported ($0.24) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by $0.22. The firm earned $1.03 billion during the quarter, compared to analyst estimates of $1.01 billion. Catalent had a negative trailing twelve-month return on equity of 2.43% and a negative net margin of 29.91%. The business's quarterly revenue was down 10.2% on a year-over-year basis. During the same period in the previous year, the business posted $0.62 earnings per share.

ETFs with the largest weight of Catalent (NYSE:CTLT) stock in their portfolio include IQ Merger Arbitrage ETF (MNA), SPDR S&P Pharmaceuticals ETF (XPH), Direxion Daily Pharmaceutical & Medical Bull 3X Shares (PILL), First Trust Merger Arbitrage ETF (MARB), iShares U.S. Pharmaceuticals ETF (IHE), VanEck Pharmaceutical ETF (PPH), ProShares Merger ETF (MRGR) and Amplify AI Powered Equity ETF (AIEQ).

391 employees have rated Catalent Chief Executive Officer John R. Chiminski on Glassdoor.com. John R. Chiminski has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Catalent investors own include Abbott Laboratories (ABT), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Johnson & Johnson (JNJ), NVIDIA (NVDA), Alibaba Group (BABA), Bristol-Myers Squibb (BMY), AT&T (T) and Cisco Systems (CSCO).

Catalent's stock is owned by a variety of institutional and retail investors. Top institutional investors include Mountain Pacific Investment Advisers Inc. ID (0.02%), Czech National Bank (0.02%), Clearview Wealth Advisors LLC (0.00%), Los Angeles Capital Management LLC (0.00%), Contravisory Investment Management Inc. (0.00%) and Sound Income Strategies LLC (0.00%). Insiders that own company stock include Alessandro Maselli, Aristippos Gennadios, Associates LP Ta, Charles Lickfold, Gregory T Lucier, John J Greisch, John R Chiminski, John R Chiminski, Jonathan Arnold, Karen Flynn, Kay A Schmidt, Manja Boerman, Mario Gargiulo, Michael A Riley, Michael J Grippo, Michelle R Ryan, Peter Zippelius, Ricardo Pravda, Ricci S Whitlow, Ricky Hopson, Scott Gunther, Steven L Fasman, Steven L Fasman, Thomas P Castellano and Thomas W Hawkeswood.
View institutional ownership trends.

Shares of CTLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.